CPRIT leaders enjoy campus tour showcasing cancer research initiatives and capabilities
Senior officials from the Cancer Prevention and Research Institute of Texas visited Rice Nov.11 for a firsthand, comprehensive look at the university’s cancer-focused collaborative research initiatives and innovation-driven facilities and labs.
Lung cancer awareness walk brings over 250 people to Rice Stadium
The Rice community came together in a display of unity and purpose for the LUNGevity Breathe Deep Together Walk at Rice Stadium Nov. 16.
Rice student group brings awareness to lung cancer
Rice American Lung Cancer Screening Initiative, the local branch of the national student-led nonprofit organization dedicated to raising awareness of and access to lung cancer screening, is bringing attention to lung cancer during National Lung Cancer Awareness Month in November.
Rice and MD Anderson launch initiative to advance cancer-focused operations research
Rice and The University of Texas MD Anderson Cancer Center today announced the launch of the Center for Operations Research in Cancer, a joint initiative to solve complex challenges in cancer care using data science to make better operational decisions.
Rice bioengineers develop lotus leaf-inspired system to advance study of cancer cell clusters
Rice bioengineers have harnessed the lotus effect to develop a system for culturing cancer cell clusters that can shed light on hard-to-study tumor properties. The new zinc oxide-based culturing surface mimics the lotus leaf surface structure, providing a highly tunable platform for the high-throughput generation of three-dimensional nanoscale tumor models.
New CPRIT chemistry professor to enhance cancer research at Rice
Rice’s Department of Chemistry will soon welcome Professor David Sarlah.
Rice researchers stride to unlock mysteries of human development
A research team from Rice University led by Aryeh Warmflash has made strides in understanding the processes that guide human embryonic development. The group’s findings were published in the scientific journal Cells Systems May 15.
Rice, Baylor College of Medicine centers jointly award seed grants
Rice University’s Synthesis X Center (SynthX) and Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center have jointly awarded their first innovation seed grants to three teams of research collaborators from Rice and Baylor.
Rice study unlocks breakthrough for breast cancer bone metastases
Rice University researchers in the lab of chemist Han Xiao have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients.
Feds fund $45M Rice-led research that could slash US cancer deaths by 50%
The Advanced Research Projects Agency for Health has awarded a Rice-led team $45 million to rapidly develop an implant with sense-and-respond technology that could slash U.S. cancer-related deaths by more than 50%.
Cellular process that fuels plant growth yields surprising insights
A new study by Rice University bioscientists explains how structures inside plant cells collaborate to fuel germination. The findings could shed light on corresponding mechanisms in human cells.
New enzyme could aid anticancer drug development
Retracing nature’s steps, Rice University engineer Xue Gao and her team mapped out the full series of enzyme-powered reactions a marine fungus uses to produce a complex molecule with anticancer properties. In the process, the Gao lab uncovered the first fungal enzyme of its kind known to break an amide bond.
DNA test could broaden access to cervical cancer screening
Rice bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that could make cervical cancer screening more accessible in low- and middle-income countries where the disease kills more than 300,000 women each year.
Rice U. chemist leverages heterogeneity for insight into catalysis, cancer initiation
Rice U. chemist Anatoly Kolomeisky has won a National Science Foundation award to study the role of heterogeneity in chemical and biological processes.
Rice, Baylor developing ‘glyco-immune’ checkpoint inhibitor
Researchers from Rice and Baylor College of Medicine are developing a first-of-its-kind “glyco-immune” checkpoint inhibitor for breast cancer survivors who develop metastatic bone cancer.
